Polyphenols in the Central Nervous System: Cellular Effects and Liposomal Delivery Approaches

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Neurodegenerative and neuroinflammatory diseases are linked to aging, oxidative stress, and inflammation.
• Polyphenols possess antioxidant and anti-inflammatory properties, modulating key cellular pathways and neurogenesis.
• Alzheimer's disease, Parkinson's disease, and multiple sclerosis are central nervous system conditions with shared underlying pathologies.

Purpose of the Study:

• To review the cell-specific neuroprotective actions of polyphenols in neurons, astrocytes, microglia, and oligodendrocytes.
• To explore the therapeutic potential of polyphenols in neurodegenerative diseases.
• To discuss strategies for overcoming polyphenol bioavailability limitations.

Main Methods:

• Literature review of studies on polyphenol mechanisms and delivery systems.
• Analysis of cell-specific effects of polyphenols on neural cells.
• Evaluation of liposomal nanocarriers and intranasal delivery for enhanced polyphenol efficacy.

Main Results:

• Polyphenols modulate critical signaling pathways (PI3K/Akt, MAPK, Nrf2, CREB) and regulate neurogenesis and microglial activation.
• Poor bioavailability (instability, low solubility, limited blood-brain barrier penetration) hinders polyphenol therapeutic use.
• Liposomal nanocarriers, including functionalized variants, demonstrate enhanced in vitro and in vivo efficacy of polyphenols.

Conclusions:

• Polyphenols hold significant promise as neuroprotective agents for central nervous system disorders.
• Liposome-based delivery platforms can substantially improve the clinical potential of polyphenols.
• Further research into formulation and targeting is crucial for optimizing liposomal polyphenol therapies.